Geometry.Net - the online learning center
Home  - Health_Conditions - Bone Disorders
e99.com Bookstore
  
Images 
Newsgroups
Page 7     121-126 of 126    Back | 1  | 2  | 3  | 4  | 5  | 6  | 7 
A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

         Bone Disorders:     more books (100)
  1. Less is more (bone): yearly osteoporosis drug reduces fractures.(This Week): An article from: Science News by Brian Vastag, 2007-05-05
  2. Staving off bone loss: new thinking on when women need medications to treat osteoporosis--and how long to take them.(BODY WORKS): An article from: Food & Fitness Advisor by Gale Reference Team, 2007-04-01
  3. Teriparatide shown to strengthen bone: awaiting FDA approval for osteoporosis. (Clinical Rounds).(parathyroid hormone): An article from: Family Practice News by Betsy Bates, 2002-04-15
  4. Zoledronic acid once yearly slows osteopenia loss: benefit seen in elderly after hip fracture.(METABOLIC DISORDERS): An article from: Family Practice News by Michele G. Sullivan, 2009-05-01
  5. Bone and Skin Disorders: Surgery of Disorders of the Hand and Upper Extremity (Surgery of Disorders of the Hand and Upper Extremity Series)
  6. Primer on the Metabolic Bone Diseases/ Disorders of Mineral Metabolism by Asbmr, 2006-01
  7. A case of skull base mucormycosis with osteomyelitis secondary to temporal bone squamous cell carcinoma.(Disease/Disorder overview): An article from: Ear, Nose and Throat Journal by Anil Safaya, Kadambari Batra, et all 2006-12-01
  8. Concomitant inflammatory pseudotumor of the temporal bone and lung: a case report.(Disease/Disorder overview)(Case study): An article from: Ear, Nose and Throat Journal by Joo Hyung Lee, Min Kyo Jung, et all 2007-10-01
  9. Alendronate increases bone density, trial confirms.(Metabolic Disorders): An article from: Family Practice News by Doug Brunk, 2006-03-01
  10. Don't stop bisphosphonates if early bone readings show loss.(Musculoskeletal Disorders): An article from: Family Practice News by Sherry Boschert, 2005-12-15
  11. Alendronate edged risedronate in BMD trial, but some skeptical.(Musculoskeletal Disorders)(bone mineral density): An article from: Family Practice News
  12. Teriparatide boosts bone density in secondary osteoporosis.(Musculoskeletal Disorders): An article from: Family Practice News by Kerri Wachter, 2007-05-15
  13. BONE DISEASE SYLLABUS (Disorders of the Skeleton) Set 2 by H.G.; Freiberger, R.H.; Et al Jaconson, 1972
  14. New osteoporosis guidelines for men: six out of every 100 men will have the disease by age 65; earlier preventive steps are recommended.(BONES & JOINTS)(Disease/Disorder ... overview): An article from: Health News by Unavailable, 2008-08-01

121. Drs Macnicol And Jackson, Oral And Maxillofacial Surgeons
Dental implants, wisdom teeth, TMJ disorders, facial trauma, bone grafting, oral pathology, maxillofacial procedures.
http://www.maxillocare.com/

MISSION STATEMENT Welcome to our practice website.
We offer you our total commitment to provide the highest quality oral surgical care in a state of the art environment. Each member of this practice will make every effort to exceed your expectations with the care you receive.
Dr. Bruce M. MacNicol
Dr. Michael T. Jackson
Dr. Andrew
Gater

122. Connecticut Children's Medical Center - Endocrinology
Offers care for infants, children, and adolescents with a wide range of endocrine and metabolic disorders, including diabetes, hypoglycemia, hyperlipidemia, growth disorders, precocious and delayed puberty, pituitary, adrenal, and thyroid abnormalities, ambiguous genitalia, disorders of calcium and bone metabolism, menstrual irregularities, and hirsutism.Š
http://www.ccmckids.org/services/endocrinology.asp
Services Programs Site Search
Overview
Staff
Office Location
Location: 2L
Telephone: 860.545.9370
Fax: 860.545.9371
Contact Person
Susan K. Ratzan, MD, Director
E-mail sratzan@ccmckids.org
The division offers care for infants, children, and adolescents with a wide range of endocrine and metabolic disorders, including diabetes, hypoglycemia, hyperlipidemia, growth disorders, precocious and delayed puberty, pituitary, adrenal, and thyroid abnormalities, ambiguous genitalia, disorders of calcium and bone metabolism, menstrual irregularities, and polycystic ovarian syndrome.
The division has a comprehensive program for the care and education of children with type 1 and type 2 diabetes utilizing a multidisciplinary team approach. Doctor Search Services Programs Investigators ... Email the President

123. The Paget Foundation
Information and programs for patients and medical professionals on Paget's disease of bone, primary hyperparathyroidism, fibrous dysplasia, osteopetrosis, breast cancer metastatic to bone, and prostate cancer metastatic to bone.
http://www.paget.org
Information On:
FOR PATIENTS
FOR HEALTH PROFESSIONALS
Welcome to the Paget Foundation!
Welcome! We invite you to register and explore the Paget Foundation website. Here you will find a wealth of accurate and reliable information on Paget's disease of bone, primary hyperparathyroidism, fibrous dysplasia, osteopetrosis (not the common disease osteoporosis) and the skeletal complications of cancer. (Please note that this website does not include information on Paget's breast disease.) As the only organization in the United States addressing these conditions, the Foundation is dedicated to providing useful information for patients, health professionals and researchers. We need your support to continue to make Paget Foundation information accessible to everyone who needs it. Please take a minute and follow the simple instructions for

124. Orlando Orthopaedic Center – Providing Orthopaedic Excellence To Central F
Orthopaedic medicine treats diseases, disorders and injuries of muscles, bones and joints.
http://www.orlandoortho.com
Orlando Orthopaedic Center was formed in 1972 by two local orthopaedic surgeons. Over the years, Orlando Orthopaedic Center has grown to include 13 Board
Certified orthopaedic surgeons and 5 central Florida locations. Privacy Contact

125. Researchers Track Down Cause Of A Disfiguring Bone Disorder
Scientists have tracked down the biological trigger that gives rise to Van Buchem disease, a hereditary, disfiguring bone disorder that can cause blindness
http://www.eurekalert.org/pub_releases/2005-06/dlnl-rtd061405.php
Public release date: 16-Jun-2005
E-mail Article

Contact: Charlie Osolin
osolin1@llnl.gov

DOE/Lawrence Livermore National Laboratory
Researchers track down cause of a disfiguring bone disorder
Missing long-range regulatory element gives rise to Van Buchem disease
DNA sleuths Jessie Chang (left), Nicole Collette and Gabriela Loots have located the regulatory element whose absence is responsible for Van Buchem disease."
Full size image available here LIVERMORE, Calif. – Scientists have tracked down the biological trigger that gives rise to Van Buchem disease, a hereditary, disfiguring bone disorder that can cause blindness and deafness. The findings provide insight into long-range gene regulation and could lead to new treatments for osteoporosis and other crippling bone disorders. A research team from Lawrence Livermore and Lawrence Berkeley national laboratories, the Novartis Institutes for BioMedical Research in Switzerland, and the DOE Joint Genome Institute in Walnut Creek, Calif., characterized a human mutation associated with the malfunctioning of the sclerostin, or SOST, gene, and showed that it plays a key role in regulating bone formation. The culprit is a regulatory element in a missing 52,000-base-pair stretch of DNA that normally directs the SOST gene to produce a protein that maintains control of bone formation rates. Without this regulator, bone production goes up, progressively increasing bone density, or osteosclerosis. The effect primarily occurs in the skull and lower jaw of Van Buchem patients, causing facial distortions and pinching cranial nerves, which can lead to deafness and blindness. Collarbones, ribs and long bones can also be affected.

126. Bone Disorder Drugs
CHC Wausau Hospital s Medical Library and Patient Education Center provides research services and healthcare information to physicians,
http://www.chclibrary.org/micromed/00040330.html

Main Search Index
Definition Purpose Description ... Resources
Bone disorder drugs
Definition
Bone disorder drugs are medicines used to treat diseases that weaken the bones. Purpose
The drugs described here are used to treat or prevent osteoporosis (brittle bone disease) in women past menopause as well as older men. They also are used prescribed for Paget's disease, a painful condition that weakens and deforms bones, and they are used to control calcium levels in the blood. Bone is living tissue. Like other tissue, bone is constantly being broken down and replaced with new material. Normally, there is a balance between the breakdown of old bone and its replacement with new bone. But when something goes wrong with the process, bone disorders may result. Osteoporosis is a particular concern for women after menopause, as well as for older men. In osteoporosis, the inside of the bones become porous and thin. Over time, this condition weakens the bones and makes them more likely to break. Osteoporosis is four times more common in women than in men. This is because women have less bone mass than men, tend to live longer and take in less calcium, and need the female hormone estrogen to keep their bones strong. If men live long enough, they are also at risk of getting osteoporosis later in life. Once total bone mass has peakedaround age 35all adults start to lose it. In women, the rate of bone loss speeds up during menopause, when estrogen levels fall. Bone loss may also occur if both ovaries are removed by surgery. Ovaries make estrogen.

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

Page 7     121-126 of 126    Back | 1  | 2  | 3  | 4  | 5  | 6  | 7 

free hit counter